MobiHealth News May 24, 2024
The continuous glucose monitoring biosensor platform will use the funds to scale its manufacturing, move toward regulatory approval and perform more clinical trials.
California-based Allez Health, formerly Zense-Life, announced it secured $60 million in Series A+ financing.
The round was led by strategic investor Osang Healthcare, with participation from existing investors.
WHAT IT DOES
Allez Health is a continuous glucose monitoring biosensor platform that uses sensor technology to improve a patient’s performance by analyzing datasets across various health afflictions.
The funding will be used to support operations and regulatory approval filings, scale manufacturing and accelerate clinical trials.
The company’s cofounders and leadership team are made up of former Dexcom leaders.
Allez Health’s chief executive officer, Leif...
Today's Sponsors
Today's Sponsor